Literature DB >> 24642336

CD34+/CD45-dim stem cell mobilization by hyperbaric oxygen - changes with oxygen dosage.

Marvin Heyboer1, Tatyana N Milovanova2, Susan Wojcik1, William Grant1, Mary Chin2, Kevin R Hardy2, David S Lambert2, Christopher Logue2, Stephen R Thom3.   

Abstract

Because hyperbaric oxygen treatment mobilizes bone marrow derived-stem/progenitor cells by a free radical mediated mechanism, we hypothesized that there may be differences in mobilization efficiency based on exposure to different oxygen partial pressures. Blood from twenty consecutive patients was obtained before and after the 1st, 10th and 20th treatment at two clinical centers using protocols involving exposures to oxygen at either 2.0 or 2.5 atmospheres absolute (ATA). Post-treatment values of CD34+, CD45-dim leukocytes were always 2-fold greater than the pre-treatment values for both protocols. Values for those treated at 2.5 ATA were significantly greater than those treated at 2.0 ATA by factors of 1.9 to 3-fold after the 10th and before and after the 20th treatments. Intracellular content of hypoxia inducible factors -1, -2, and -3, thioredoxin-1 and poly-ADP-ribose polymerase assessed in permeabilized CD34+ cells with fluorophore-conjugated antibodies were twice as high in all post- versus pre-treatment samples with no significant differences between 2.0 and 2.5 ATA protocols. We conclude that putative progenitor cell mobilization is higher with 2.5 versus 2.0 ATA treatments, and all newly mobilized cells exhibit higher concentrations of an array of regulatory proteins.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24642336      PMCID: PMC4037447          DOI: 10.1016/j.scr.2014.02.005

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  53 in total

1.  Stem cell mobilization by hyperbaric oxygen.

Authors:  Stephen R Thom; Veena M Bhopale; Omaida C Velazquez; Lee J Goldstein; Lynne H Thom; Donald G Buerk
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-11-18       Impact factor: 4.733

2.  Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment.

Authors:  Mihail Hristov; Christian Fach; Carolin Becker; Nicole Heussen; Elisa A Liehn; Rüdiger Blindt; Peter Hanrath; Christian Weber
Journal:  Atherosclerosis       Date:  2006-07-11       Impact factor: 5.162

3.  Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide.

Authors:  Lee J Goldstein; Katherine A Gallagher; Stephen M Bauer; Richard J Bauer; Vijay Baireddy; Zhao-Jun Liu; Donald G Buerk; Stephen R Thom; Omaida C Velazquez
Journal:  Stem Cells       Date:  2006-06-22       Impact factor: 6.277

4.  Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34⁺ cells in a murine model of umbilical cord blood transplantation.

Authors:  Omar S Aljitawi; Yinghua Xiao; Jeff D Eskew; Nikhil K Parelkar; Megan Swink; Jeff Radel; Tara L Lin; Bruce F Kimler; Jonathan D Mahnken; Joseph P McGuirk; Hal E Broxmeyer; George Vielhauer
Journal:  Blood Cells Mol Dis       Date:  2013-08-14       Impact factor: 3.039

5.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.

Authors:  T Asahara; T Takahashi; H Masuda; C Kalka; D Chen; H Iwaguro; Y Inai; M Silver; J M Isner
Journal:  EMBO J       Date:  1999-07-15       Impact factor: 11.598

6.  Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease.

Authors:  Tiffany M Powell; Jonathan D Paul; Jonathan M Hill; Michael Thompson; Moshe Benjamin; Maria Rodrigo; J Philip McCoy; Elizabeth J Read; Hanh M Khuu; Susan F Leitman; Toren Finkel; Richard O Cannon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-11-29       Impact factor: 8.311

7.  Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group.

Authors:  Djillali Annane; Joël Depondt; Philippe Aubert; Maryvonne Villart; Pierre Géhanno; Philippe Gajdos; Sylvie Chevret
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

8.  Platelet function in humans is not altered by hyperbaric oxygen therapy.

Authors:  S R Thom; D Fisher; J M Stubbs
Journal:  Undersea Hyperb Med       Date:  2006 Mar-Apr       Impact factor: 0.698

9.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Authors:  Katherine A Gallagher; Zhao-Jun Liu; Min Xiao; Haiying Chen; Lee J Goldstein; Donald G Buerk; April Nedeau; Stephen R Thom; Omaida C Velazquez
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

10.  Stem cell mobilization in HIV seropositive patients with lymphoma.

Authors:  Alessandro Re; Chiara Cattaneo; Cristina Skert; Pascual Balsalobre; Mariagrazia Michieli; Mark Bower; Andrés J M Ferreri; Marcus Hentrich; José M Ribera; Bernardino Allione; Philipp Schommers; Silvia Montoto; Camillo Almici; Pierino Ferremi; Mario Mazzucato; Salvatore Gattillo; Salvatore Casari; Michele Spina; José L Diez-Martin; Umberto Tirelli; Giuseppe Rossi
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

View more
  21 in total

1.  In search of a treatment for radiation-induced optic neuropathy.

Authors:  Maanasa Indaram; Ferhina S Ali; Marc H Levin
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

Review 2.  Topical oxygen therapy & micro/nanobubbles: a new modality for tissue oxygen delivery.

Authors:  Lohrasb R Sayadi; Derek A Banyard; Mary E Ziegler; Zaidal Obagi; Jordyne Prussak; Michael J Klopfer; Gregory Rd Evans; Alan D Widgerow
Journal:  Int Wound J       Date:  2018-01-05       Impact factor: 3.315

3.  Effect of hyperbaric air on endotoxin from Bacteroides fragilis strains.

Authors:  Dittmar Chmelař; Adéla Kašíková; Petrana Martineková; Michal Hájek; Miroslav Rozložník; Marek Brabec; Jana Janečková; Jana Vobejdová; Ivan Čižnár
Journal:  Folia Microbiol (Praha)       Date:  2017-11-13       Impact factor: 2.099

4.  Stage III Kienböck's disease treated with hyperbaric oxygen: the role of an unusual approach to a rare condition.

Authors:  Paulo Jorge Figueira; Diogo Alpuim Costa; Nunzio Barbagallo; Francisco Gamito Guerreiro
Journal:  BMJ Case Rep       Date:  2018-10-12

5.  The effect of hyperbaric oxygenation therapy on myocardial function.

Authors:  Marina Leitman; Shai Efrati; Shmuel Fuchs; Amir Hadanny; Zvi Vered
Journal:  Int J Cardiovasc Imaging       Date:  2020-01-17       Impact factor: 2.357

6.  Only minor stem cell mobilization in head and neck irradiated patients treated with hyperbaric oxygen.

Authors:  Lone Forner; Adela Berkowicz; Ebbe Dickmeiss; Ole Hyldegaard; Erik C Jansen; Anne Fischer-Nielsen
Journal:  Diving Hyperb Med       Date:  2019-09-30       Impact factor: 0.887

7.  Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process.

Authors:  Christopher Dunnill; Thomas Patton; James Brennan; John Barrett; Matthew Dryden; Jonathan Cooke; David Leaper; Nikolaos T Georgopoulos
Journal:  Int Wound J       Date:  2015-12-21       Impact factor: 3.315

Review 8.  Hyperbaric oxygen therapy for acute coronary syndrome.

Authors:  Michael H Bennett; Jan P Lehm; Nigel Jepson
Journal:  Cochrane Database Syst Rev       Date:  2015-07-23

9.  A Dual Role for Hyperbaric Oxygen in Stroke Neuroprotection: Preconditioning of the Brain and Stem Cells.

Authors:  Grant M Liska; Trenton Lippert; Eleonora Russo; Norton Nieves; Cesar V Borlongan
Journal:  Cond Med       Date:  2018-06

10.  Measurements of CD34+/CD45-dim Stem Cells Predict Healing of Diabetic Neuropathic Wounds.

Authors:  Stephen R Thom; Michelle Hampton; Michael A Troiano; Ziad Mirza; D Scot Malay; Steven Shannon; Nathan B Jennato; Cornelius M Donohue; Ole Hoffstad; Diana Woltereck; Ming Yang; Kevin Yu; Veena M Bhopale; Svitlana Kovtun; David J Margolis
Journal:  Diabetes       Date:  2015-10-20       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.